bpc 157 legality united states fda status BPC-157 Before the FDA: Briefing Document Focuses on… From BPC-157 to TB-500 to
Description
That concentration of authorship is a documented limitation of the evidence base and is factored into every assessment below
Optimal seems to be 8-12 weeks for chronic issues

D.WebsterH
Not sure if this is normal
